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The pig is a valuable animal model to study obesity in humans due to the physiological 
similarity between humans and pigs in terms of digestive and associated metabolic processes. 
The dietary use of vegetal protein, probiotics and omega-3 fatty acids is recommended to 
control weight gain and to fight obesity-associated metabolic disorders. Likewise, there are 
recent reports on their beneficial effects on brain functions. The hypothalamus is the central 
part of the brain that regulates food intake by means of the production of food intake-
regulatory hypothalamic neuropeptides, as Neuropeptide Y (NPY), Orexin A and pro-
opiomelanocortin (POMC), and neurotransmitters such as dopamine and serotonin. Other 
mesolimbic areas such as the hippocampus are also involved in the control of food intake. In 
this study, the effect of a high fat diet (HFD) alone or supplemented with these additives on 
brain neuropeptides and neurotransmitters was assessed in forty-three young pigs feed for 10 
weeks with a control diet (T1), a high fat diet (HFD, T2), and HFD with vegetal protein 
supplemented with Bifidobacterium breve CECT8242 alone (T3) or in combination with 
omega-3 fatty acids (T4). A HFD provoked changes in regulatory neuropeptides and 3,4-
dihydroxyphenylacetic acid (DOPAC) in the hypothalamus and alterations mostly in the 
dopaminergic system in the ventral hippocampus. Supplementation of the HFD with B. breve 
CECT8242, especially in combination with long chain polyunsaturated omega-3 fatty acids, 
was able to partially reverse the effects of HFD. Correlations between productive and 
neurochemical parameters supported these findings. These results confirm that pigs are an 
appropiate animal model alternative to rodents for the study of the effects of HFD on weight 
gain and obesity. Furthermore, they indicate the potential benefits of probiotics and omega-3 
fatty acids on brain function.  
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Obesity, which is characterized by excessive fat mass accumulation, has been a rising 
problem for the past several decades. Due to the importance of obesity and eating disorders, 
the investigation of food intake control mechanisms is a big issue (Stevens et al., 2012). This 
control is exerted by several physiological mechanisms, including stomach and gut-derived 
signals, and metabolic hormones such as leptin and insulin (Mantzoros et al., 2011). Besides 
these peripheral circuits, the regulation of appetite consists in a complex interaction between 
the body and the brain, which controls the homeostasis as well as the motivational (hedonic) 
aspects of food intake (Yu and Kim, 2012). In this context, one key interface linking the brain 
to the organism is the gut–brain axis, i.e., the multimodal bidirectional communication system 
between the gastrointestinal (GI) tract and the brain (Weltens et al., 2018). 
 
The hypothalamus (HPT) is the central part of the brain that regulates food intake, 
coordinating global energy metabolism and appetite. It operates as a neuroendocrine 
transducer, sensing peripheral endocrine signals and transforming them into neurotransmitter 
(NT) events that deliver the homeostatic response back to the periphery (Yu and Kim, 2012). 
After a meal, circulating leptin enters the brain and reaches the arcuate nucleus (ARC), which 
is the main feeding behaviour-regulatory area in the HPT. In the ARC, two first-order neuron 
populations exist. One of them is a group of neurons producing the orexigenic peptides 
Neuropeptide Y (NPY) and Agouti-related peptide (AgRP) and the other is a subset of 
neurons expressing anorexigenic neuropeptides, like proopiomelanocortin (POMC) and 
cocaine- and amphetamine-regulated transcript (CART) (Schwartz et al., 2000; Sobrino 
Crespo et al., 2014). Leptin binding to its receptor in the ARC reciprocally activates the 
anorexigenic POMC/CART neurons and inhibits the orexigenic NPY/AgRP neurons leading 
to a decrease in food intake. Like leptin, insulin binds insulin receptors on ARC neurons, 
resulting in activation of POMC neurons and inhibition of NPY/AgRP neurons. These 
neuropeptides act on second-order neurons, localized in other hypothalamic areas. α-
Melanocyte stimulating hormone (α-MSH), produced by the posttranscriptional processing of 
POMC, activates catabolic pathways reducing food intake, thus acting as an anorexigenic 
neuropeptide, whereas the orexigenic neuropeptide Orexin A is produced in response to 
NPY/AgRP (Fernø et al., 2015). High fat diet induced-obesity is also characterized by 
alterations in the HPT neuropeptide pattern, although some controversy exists in the literature 
due to the diversity of animal models, diet composition and duration of these studies (Gumbs 
et al., 2016).  
Although it is clear that the HPT has a main role in the control of the homeostasis of body 
weight, it is becoming evident that a relationship exists between the hypothalamic circuits and 
the mesolimbic and mesocortical monoaminergic systems (Gumbs et al., 2016). For instance, 
orexin neurons project onto dopaminergic neurons in the ventral tegmental area (VTA) and 
connect orexigenic signals to the mesocorticolimbic dopamine (DA) system of the brain (van 
Zessen et al., 2012). DA is believed to be mainly anorexigenic since leptin acts on DA 
neurons in the VTA to suppress feeding (Hommel et al., 2006). On the other hand, serotonin 
(5-HT) acts on POMC neurons through the 5HT-2C receptor to induce anorexia (Lam et al., 
2010). Outside the HPT, several authors have highlighted the deleterious effects of a HFD on 
the hippocampus (HC) function, mostly related to cognition, including memory processes, 




The concept of the gut-brain axis has been recently enriched with the evidence pointing to the 
influence of the gut microbiota being essential not only for gut health but also for normal 
physiologic functioning in other organs, especially the brain, giving rise to the “brain-gut-
microbiome axis”, defined as the bidirectional communication system enabling gut microbes 
to communicate with the brain and the brain with the gut (Bienenstock et al., 2015; Dinan and 
Cryan, 2017). The use of vegetal protein and probiotics have been largely suggested as 
therapeutic strategies to fight HFD-induced obesity as well as obesity-associated pathologies 
(Arora et al., 2013; Nova et al., 2016). Several species and strains of Lactobacillus and 
Bifidobacterium have been used in rodent animal models that have demonstrated positive 
effects on obesity reduction (Chen et al., 2012; Kondo et al., 2010; Shin et al., 2017), obesity-
associated inflammation (Cano et al., 2013), lipid metabolism (Moya-Pérez et al., 2014; Yoo 
et al., 2013), metabolic syndrome (Kondo et al., 2013), insulin-sensitivity (Bagarolli et al., 
2017), HFD-altered vascular function (Mauricio et al., 2017), HFD-induced colitis (Lim and 
Kim, 2017) and steatohepatitis (Reichold et al., 2014). Studies in human patients have also 
reported the beneficial effects of probiotics on metabolic syndrome and obesity (Bernini et al., 
2016; Minami et al., 2015). Similarly, dietary omega-3 fatty acids improve obesity-associated 
metabolic disorders in mice and humans (Huang et al., 2016; Lorente-Cebrián et al., 2013; 
Martínez-Fernández et al., 2015). Although more scarce, there are recent reports on the 
beneficial effects of probiotics and unsaturated fatty acids on cognitive functions in human 
studies and rodent models (Beilharz et al., 2015; Kang and Gleason, 2013; Noble et al., 2017). 
In the scope of the gut-brain-microbiome axis, the name of psychobiotics is starting to be used 
in the literature, related to the recent research field that relates the microbiota of the intestine 
with diseases of the nervous system and its possible treatment (Bermúdez-Humarán et al., 
2019).  
 
The majority of studies on the brain components of appetite control have been performed in 
rodents, but these animal species present some limitations when compared to humans, in 
metabolic as well as neuronal aspects. Instead, pigs have been used as a model for obesity and 
obesity-related diseases due to the physiological similarity between humans and pigs in terms 
of digestive and associated metabolic processes (Bassols et al., 2014; Koopmans and 
Schuurman, 2015). The interaction with gut microbiota has been also studied in the porcine 
model (Heinritz et al., 2013). Furthermore, in an ongoing study in a porcine model fed with a 
HFD, we have previously showed that the use of rice protein hydrolysate, the probiotic 
Bifidobacterium breve CECT8242 and omega-3 fatty acids prevented excessive weight gain 
and dyslipidemic alterations associated with obesity in this model (Serrano et al., 2016). 
The objective of the present work was to analyse the effect of a HFD on brain monoaminergic 
neurotransmitters (NTs) and neuropeptides involved in the regulation of appetite in young 
pigs. Under the hypothesis of the gut microbiota – brain axis, the second goal was to ascertain 
whether, in animals fed this HFD, the use of a rice protein hydrolysate, with B. breve 
supplementation alone or in combination with omega-3 fatty acid was able to counterbalance 
these central effects. In the overall, we wanted to assess whether changes in food intake or 
body weight induced by these dietary supplements could be explained by a modification of 




Animals used in this experiment (female, n = 43) were obtained from 12 swine pure breed 
Duroc contemporary litters. After weaning, animals were moved to the IRTA experimental 
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station starting a period of adaption feed with a standard diet. Care and management 
procedures were approved by the IRTA bioethics committee (DAAM 7306/2013). At 9 weeks 
of age animals were located in environmentally monitored facilities, randomly distributed in 4 
pens (10 to 11 animals per pen from different litters) and fed ad-libitum for 10 weeks with 4 
different diets (treatments T1 to T4). Each pen had a partly slatted floor (60% solid concrete 
and 40% slatted), with some sawdust provided on the concrete floor on a regular basis and a 
natural light cycle, with a minimum of intensity of 40 lux (EU legislation on pig welfare) and 
8 hours light. The room temperature was maintained at 22 +- 5 ºC.  
Fresh water was provided to all animals and individual daily voluntary feed consumption was 
obtained using an automatic feeding recording system. Weight gain and food intake were 
obtained weekly during the growing period. Experimental diets were elaborated at the IRTA 
experimental mill, with different components: cereal, vegetal or milk protein, starch, sugar 
and minerals, micronutrients and amino acids in different percentages (see Table S1). 
Estimated nutritive composition of diets are reported in Table 1.  All animals received an 
additional daily ration of 18 grams soft cheese (with a 14% crude protein and 14% fat with a 
total of 42 Kcal of energy). T1 was a control diet according to the NRC (Nutrition Resource 
Center) recommendations. T2 was a western diet formulated with a high fat content of animal 
origin (lard) and protein of animal origin (caseinate). T3 and T4 contained soft cheese 
including 5·1010cfu/day B. breve CECT8242 probiotic. T4 included long chain 
polyunsaturated omega-3 fatty acids (1 g stearidonic acid (SDA) and 2 g docosahexaenoic 
acid (DHA) per 100 g fat). 
 
Supplementary Table S1. Components of experimental diets T1 to T4 (in percentage)  
 
Table 1. Nutritive composition of experimental diets (percentages versus 
total food weight)  




  T1 T2 T3 T4 
Crude Protein (%) 17,6 14,34 14,54 14,62 
Crude Fibre (%) 11 1,71 1,75 1,74 
Fat (%) 4,6 11,55 11,92 12,09 
Sodium %  0,15 0,15        0,15 0,15 
Calcium %  0.80 0.70 0.80 0.80  
Ash (%) 5.55 4.13 4.15 4.15 
Lysine (%) 1,03 0,93 0,93 0,93 
Phosphorous (%) 0.56 0.49 0.51 0.51 
Lysine (%) 0.99 0.90 0.90 0.90 
Threonine (%) 0.66 0.57 0.57 0.57 
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Methionine (%) 0.36 0.37 0.37 0.37 
Tryptophan (%) 0.23 0.20 0.18 0.18 
Energy (MJ/kg) 10,83 15,16 15,56 15,56 





- - 5·1010 5·1010 
Omega-3 fatty acids (% 
total fatty acids)  
- - - 3 
 
Brain collection and dissection 
Animals were fasted 8 h before being transported from the experimental farm to the 
experimental slaughterhouse (1.2 km of distance). After the unloading, pigs were located in 
the lairage pens for an hour. Animals were stunned in groups of two by exposure to 90 % CO2 
at atmospheric air for 3 min and exsanguinated afterwards. 
Brain was removed from skull immediately after slaughter. Brain areas (prefrontal cortex 
(PFC), amygdala (Amg), ventral hippocampus (VHC), dorsal hippocampus and hypothalamus 
(HPT)) were excised as quickly as possible, frozen in liquid nitrogen and kept at -80 °C until 
analysis. 
Determination of neurotransmitters by HPLC  
Brain samples were weighted and homogenized by sonication (Branson Digital Sonifier 250, 
Branson Ultrasonics Corp., Danbury, CT) with 0.3 mg tissue/ 1 µL lysis buffer (150 
mMNaCl, 50 mMTris-HCl, 0.1 % NP-40 and pH 7.5). This lysis buffer is compatible with all 
techniques used in this study. Dihydroxybenzylamine (DHBA) was added to the lysis buffer 
at 300 pg/µL as internal standard. Proteins in brain lysates were precipitated by adding 0.25 
M perchloric acid containing 0.1 M sodium metabisulfite (Na2S2O5) and 0.25 M 
ethylenediaminetetraacetate (EDTA)) in a 1.5 (v/v) ratio. Finally, samples were centrifuged at 
12000 g for 10 minutes at 4 °C and the supernatant was kept at -80 °C until analysis. 
The concentration of NTs from different brain areas was determined by high performance 
liquid chromatography (HPLC) in an Elite LaChrom system (Merck-Hitachi, Prague, The 
Czech Republic) equipped with Cromolith Rp-18e column (Merck, Darmstadt, Germany) 
with electrochemical detection (ESA Coulochem II 5200). The mobile phase consisted of 500 
mM citrate buffer pH 2.8-3.0, 0.05 mM EDTA, 1.2 mM sodium octyl sulphate (SOS) and 1 % 
acetonitrile. The flow rate was 1mL/min and the voltage applied to the detector was set at 400 
mV. Twenty µL of supernatant were injected in the HPLC for the quantification of 
noradrenaline (NA), dopamine (DA) and its metabolites 3,4-dihydroxyphenylacetic acid 
(DOPAC) and homovanillic acid (HVA) and the indoleamines serotonin (5-HT) and its 
metabolite 5-hydroxyindoleacetic acid (5-HIAA) (Arroyo et al., 2016). 
Quantification of neuropeptides 
Neuropeptides were determined in lysates prepared from hypothalamus. The orexigenic 
neuropeptides Orexin A (OrexA) and Neuropeptide Y (NPY) and the anorexigenic 
neuropeptide Proopiomelanocortin (POMC) were quantified by ELISA (EIA anti-Orexin A, 
Phoenix Pharmaceuticals, Burlingame, CA, USA; EIA Porcine Anti-Neuropeptide Y, Phoenix 
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Pharmaceuticals, Burlingame, CA, USA; ELISA Porcine Anti-POMC, Neobiolab, 
Cambridge, MA, USA). 
Statistical analysis 
Data presented on this study was analysed using IBM SPSS software (IBM SPSS v22). 
Shapiro–Wilk normality test of descriptive data was performed and logarithmic data was 
transformation of data was calculated if necessary. ANOVA and Tukey as a Post-Hoc test 
was applied, with a P<0.05 of significance level and 0.05≤P≤0.1 for tendency, to analyse 
differences between conditions. Correlation between variables was analysed with two-tailed 
Pearson’s test. Only correlations with coefficients higher than 0.5 and P<0.05 were 




Data on weight, weight gain and food intake are shown in Table 2. All four groups had 
similar initial weight at week 9. At week 18, at the end of diet treatments, animals in T3 and 
T4 had similar weight than those in T1 (control diet) and lower than T2 (high-fat diet, HFD) 
(P=0.02). A similar result is observed when measuring the weight gain throughout the 
experiment (week 9 to week 18) (P==0.01) and the ADG (P=0.01). In all cases, there were no 
differences between T1, T3 and T4. 
Regarding food intake measured in kg, there were no differences due to HFD vs the control, 
in total food intake or daily food intake. Nevertheless, treatment with probiotics and omega-3 
fatty acids (T4) decreased food intake when compared to the control group (P=0.002). A 
tendency was observed when T3 and T4 were compared to T2 (P=0.057). 
When determining food intake measured in kcal, individuals in the HFD group increased their 
total and daily energy intake when compared to the control group. Animals in T3 and T4 also 
had higher energy intake when compared to T1 (P<0.001). A tendency was observed for the 
T4 group when compared to T2 (P=0.076). 
Table 2. Effects of dietary treatments on weight gain, average daily gain (ADG) and food intake in 
young pigs 
     
Treatment T1 T2 T3 T4 
n 11 10 11 11 
  mean +/- SE Mean +/- SE Mean +/- SE Mean +/- SE 
Weight W9 (kg) 16,50 +/- 0,86 16,70 +/- 0,70 16,14 +/- 0,59 16,27 +/- 0,41 
Weight W18 (kg) 53,27 +/- 1,74 
a,b 60,00 +/- 2,65 b 51,36 +/- 2,12 a 50,23 +/- 2,07 a 
Weight gain W9-W18 (kg) 36,77 +/- 1,27 
a,b 43,30 +/- 2,26 b 35,23 +/- 1,62 a 33,95 +/- 1,90 a 
ADG W9-W18 (kg) 0,583 +/- 0,020 
a,b 0,687 +/- 0,036 b 0,559 +/- 0,026 a 0,539 +/- 0,030 a 
Food Intake W9-W18 (kg) 92,12 +/- 1,72 
b 89,48 +/- 2,80 a,b 82,67 +/- 2,66 a,b 79,57 +/- 3,34 a 
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Daily Food Intake W9-W18 (kg) 1,462 +/- 0,028 
b 1,419 +/- 0,443 a,b 1,314 +/- 0,042 a,b 1,264 +/- 0,053 a 
Food Intake W9-W18 (kcal) 240,65 +/- 4,49 
a 328,48 +/- 10,30 b 307,24 +/- 8,99 b 295,70 +/- 12,39 b 
Daily Food Intake W9-W18 (kcal) 3,82 +/- 0,07 
a 5,21 +/- 0,16 b 4,88 +/- 0,16 b 4,69 +/- 0,20 b 
Different superscript indicates significant differences (P < 0.05) 
  
 
Brain neurotransmitter profile 
NTs of the catecholamine and indoleamine pathways were analysed in HPT and HC, and 
results compared between treatments in each brain region. No significant changes were 
observed in the PFC and the amygdala (not shown). Most of the observed changes are related 
to the dopaminergic pathway (Table 3). 
In the HPT, the concentration of DOPAC in groups treated with probiotics (T3 and T4) was 
similar to control and lower than T2 (P=0.016). The HC was divided in two areas, the dorsal 
and ventral HC, due to their different functional role (Fanselow and Dong, 2010). No 
significant differences were observed in dorsal HC. In the ventral HC, a decrease in 
dopaminergic NTs was observed, the most relevant change being the decrease in DA in T2 
compared to T1 (P=0.065). A similar pattern was observed for the metabolite DOPAC, 
although it did not reach statistical significance (P=0.072), which was partially reversed in 
T4. The total DA-system, calculated as the sum of dopaminergic compounds (DA, DOPAC 
and HVA) also decreased in T2 (P =0.049) and was reversed by supplementation, especially 
in T4 (P=0.023). Furthermore, a tendency to decrease in the serotoninergic metabolite 5-
HIAA was also observed in T2 vs T1, which was restored in T4 (P=0.096). 
Altogether, these results show that the brain system which is mainly affected by HFD is the 
dopaminergic pathway in the ventral HC of the brain regions measured. Diets with probiotics, 
especially when supplemented also with ω3-fatty acids, restore at least partially the alterations 
induced by HFD (Figure 1). 
 
Table 3. Effects of dietary treatments on the concentration of monoaminergic neurotransmitters in 
pig brain areas (ng/g tissue) 
     
Treatment T1 T2 T3 T4 
n 11 9 12 12 
  mean +/- SE mean +/- SE mean +/- SE mean +/- SE 
Hypothalamus         
NA 2082.48 ± 219.36 2036.89 ± 312.41 1906.36 ± 186.33 1883.54 ± 125.65 
DOPAC 309.20 ± 37.26 a,b 343.14 ± 28.19 a 226.71 ± 25.74 b 227.33 ± 23.37 b 
DA 228.38 ± 26.10 206.28 ± 32.40 200.98 ± 16.87 226.77 ± 30.33 
HVA 481.98 ± 51.74 537.64 ± 71.53 441.47 ± 64.74 492.23 ± 81.28 
5-HT 1055.11 ± 98.98 1134.32 ± 158.96 1074.31 ± 76.01 1104.07 ± 130.46 




        
NA 308.76 ± 10.13 342.50 ± 17.36 351.31 ± 17.67 339.48 ± 12.63 
DOPAC 147.56 ± 20.40 145.90 ± 19.31 186.64 ± 31.40 125.66 ± 15.55 
DA ND ND ND ND 
HVA 225.18 ± 39.03 188.13 ± 10.71  183.94 ± 24.96  215.31 ± 19.19  
5-HT ND ND ND ND 
5-HIAA 325.60 ± 37.82 291.14 ± 32.50 304.21 ± 13.44 309.10 ± 16.98 
Ventral hippocampus 
        
NA 279.58 ± 11.44 290.62 ± 19.06 283.73 ± 6.11 295.35 ± 11.21 
DOPAC 211.87 ± 24.90 a,b 169.64 ± 10.61 a 207.68 ± 14.05 a,b 234.40 ± 18.13 b 
DA 142.49 ± 10.72 a 91.98 ± 8.96 b 109.19 ± 11.32 a,b 122.40 ± 18.78 a,b 
HVA 190.98 ± 10.46 167.21 ± 11.40 179.11 ± 13.65 200.47 ± 16.15 
Total DA system 545.34 ± 117.03 a 428.82 ± 57.34 b 495.98 ± 74.12 a,b 557.26 ± 128.77 a 
5-HT ND ND ND ND 
5-HIAA 330.65 ± 26.96 a,b 275.47 ± 11.27 a 297.93 ± 14.06 a,b 336.34 ± 14.61 b 
     
ND: non detectable 
    
Different superscript indicates significant differences (P < 0.05). Superscript in italics indicates statistical 




Figure 1. Alterations in neurotransmitter concentration exerted by dietary treatment in 
hypothalamus (HPT) and ventral hippocampus (VHC).  
 
Neuropeptide profile in the hypothalamus 
Results obtained by ELISA in hypothalamic extracts are shown in Figure 2 and Table 4. The 
orexigenic neuropeptides Orexin A and NPY showed similar patterns since they were lower 
in HFD compared to the control group T1. The decrease was reversed in the probiotic-treated 
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groups T3 and T4. In contrast, the concentration of the anorexigenic peptide POMC increased 
after HFD and was partially normalized when the animals were treated with probiotics with or 
without omega-3 fatty acids. Nevertheless, differences did not reach statistical significance 
possibly due to the high biological variability between individuals. 
Table 4. Effects of dietary treatments on the concentration of  neuropeptides in pig 
hypothalamus (ng/g tissue) 
     
Treatment T1 T2 T3 T4 
n 11 9 12 12 
Hypothalamus mean +/- SE mean +/- SE mean +/- SE mean +/- SE 
Orexin A 2.15 ± 0.96 1.45 ±  0.46 2.38 ± 0.70 2.97 ± 1.04 
NPY 50.24  ±  11.89 29.71 ± 3.34 40.49 ± 5.37 39.15 ± 4.59 
POMC 9.57 ±  2.45 15.62 ±  4.38 12.44 ± 1.87 13.50 ± 2.30 
 
Figure 2. Hypothalamic neuropeptide concentration in young pigs under different dietary 
treatments. 
 
Correlation between variables 
All results from productive data and NT and neuropeptide data were analysed with Pearson 
correlation according to different brain areas and diets. Results are presented in Figure 3 and 4 
as heatmaps from the same treatment and brain area. Only results for HPT and ventral HC are 
presented since those were the areas with significant results. Only correlations with 
coefficients higher than ± 0.5 and P<0.05 were considered for analysis. 
1) Hypothalamus 
In the control treatment T1, positive correlations were found between NTs in the 
dopaminergic pathway (DA, DOPAC and HVA), between DA and NA and between the 
serotoninergic pathway and the catecholamines. Neither significant positive nor negative 
correlations were found between productive parameters and NT or neuropeptides. When 
comparing T1 with T2 (HFD), clear differences were observed. First of all, the correlation 
between all productive parameters was tighter in T2 than in T1 with coefficients higher than 
0.8. Interestingly, a high correlation was found between productive parameters and 5-HT and 
its metabolite 5-HIAA and also between productive parameters and DOPAC and HVA, that 
were not observed in T1. A clear negative correlation was found between the orexigenic 
neuropeptide NPY and the NTs DA and 5-HT. 
Groups supplemented with probiotics (T3 or T4) presented different correlation profiles than 
T1 or T2. The expected correlations in productive data and within NTs were also found. In 
T3, no other correlations were detected except a positive correlation between NA and the 
neuropeptides, specially Orexin A and POMC. In T4, a positive correlation was found 
between productive data and the orexigenic neuropeptides Orexin A and NPY, whereas a 
negative correlation was found between productive data, 5-HIAA and, in some cases, 
DOPAC or HVA. A negative correlation appeared also between Orexin A and DA and 5-
HIAA, and also between NPY and 5-HIAA. 
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Figure 3. Correlation heatmaps between productive parameters, neuropeptides and NTs in the 
HPT of pigs under different dietary treatments. Light grey colour represents positive 
correlations and dark grey colour represents negative correlations. Numbers correspond to 
correlation coefficients. 
 
2) Ventral Hippocampus 
Heatmaps profiles in ventral HC were different than in HPT. High correlation coefficients 
between productive parameters were found in all treatments, which were tighter in T2, T3 and 
T4 than in T1. 
Very few correlations were found between productive parameters and NTs. The exception 
was T1, where a negative correlation was observed between food intake and DOPAC and 
HVA (DA metabolites) and also to 5-HIAA as well as a positive correlation between 
productive parameters and NA. Besides, a positive correlation between productive parameters 
and HVA was observed in T2 and only a few correlations between NTs in T3 and T4. In all 
cases, correlation coefficients are lower than in the HPT.  
Figure 4. Correlation heatmaps between productive parameters, neuropeptides and NTs in the 
VHC of pigs under different dietary treatments. Light grey colour represents positive 




In the pig model used in the present study, the effects of HFD (T2) compared to the control 
group (T1) were first evaluated. It should be taken into account that brain samples in these 
pigs were obtained in animals fasted for 8 hours. Indeed, plasma insulin concentration did not 
differ between groups (data not shown). This implies that the changes described in the present 
work are not due to the short-term response after a meal. This discussion will approach the 
changes provoked by HFD and their potential restoration after dietary intervention with 
probiotics and/or omega-3 fatty acids separately in the HPT and the ventral HC, since it is 
believed that the HPT is the brain area mainly responsible for the homeostatic control of food 
intake, whereas the HC is involved in the hedonic control, i.e., other aspects of appetite-
influencing behaviours such as mood and reward.  
 
The effects of a HFD (T2 versus T1) in the NT and neuropeptide profiles in HPT and ventral 
HC 
In the HPT, the orexigenic NPY and Orexin A decreased whereas the anorexigenic peptide 
POMC increased, similar to many models of diet-induced obesity in rodents. Although the 
specific effects may depend on the duration and type of the dietary intervention, it has been 
generally described that HFD decreased NPY in the HPT, at the mRNA as well as peptide 
level, especially after a prolonged HFD, similar to the present porcine model (Dziedzic et al., 
2007; Gumbs et al., 2016; Morris et al., 2008; Stricker-Krongrad et al., 1998; Wang et al., 
2002). Similar results have been reported with OrexinA (Nobunaga et al., 2014; Park et al., 
2004). In the obesity-susceptible C57BL/6J strain of mice subjected to HFD for 2 weeks, an 
increase in the expression of POMC has been also described (Ziotopoulou et al., 2000). In the 
present study, differences did not reach statistical significance possibly due to the high 
individual variability, but the data existing in the literature support our results. Furthermore, 
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an increase in the concentration of DOPAC was observed, indicating an increase in the 
dopaminergic pathway activity. DA is considered to be an anorexigenic signal in the HPT, 
which is involved in the homeostatic control of food intake (Schwartz et al., 2000). Strong 
positive correlations between DOPAC or HVA and food intake or weight gain confirmed 
those relations between the dopaminergic pathway and food intake. Concurrently, a positive 
correlation was observed between 5-HT or 5-HIAA and food intake or weight gain, as 
described (Lam et al., 2010). The correlation heatmap obtained in T2 also reveals negative 
correlations between NPY and DA or 5-HT which support the hypothesis of DA and 5-HT 
having an anorexigenic role in the HPT (Lam et al., 2010; Schwartz et al., 2000), and also 
suggesting an inhibitory interaction between NPY and DA or 5-HT.  
In the HC, the dopaminergic system is mostly affected by HFD, since there is a decrease in 
DA, DOPAC, as well as the sum of all DA metabolites (total DA system), indicating 
inactivation of this pathway. The decrease in the DA pathway was observed in the ventral 
HC, which is believed to be related to emotion, stress and affect, whereas the role of dorsal 
HC is related to cognitive functions (Fanselow and Dong, 2010). As mentioned above, after 
food intake or a HFD, the DA decrease observed on ventral HC could be provoked by the 
inhibition of the mesocorticolimbic DA system in the VTA where the DA secretion is 
inhibited directly by leptin (Palmiter, 2007) and α-MSH via intermediate GABAergic 
synapses between ARC and VTA (van Zessen et al., 2012). These results confirm the notion 
of the orexigenic function of DA in brain areas like the HC (Schwartz et al., 2000). The 
correlation heatmaps in the HC were quite different from the HPT. A negative correlation is 
observed between weight gain and food intake and the monoaminergic pathways. 
The effects of a dietary intervention (T3 and T4) in the NT and neuropeptide profiles in HPT 
and ventral HC 
The inclusion of B. breve CECT 8242 as probiotic alone (T3) or together with omega-3 fatty 
acids (T4) caused changes in brain neuropeptides and NTs that partially reversed the 
alterations caused by HFD. In short, ventral HC dopaminergic parameters increased when 
compared to HFD to become similar to the control diet. Furthermore, hypothalamic DOPAC 
which increased in HFD, decreased to lower values than in the control diet. When comparing 
the effects of T3 and T4, the overall results suggested that the concurrent addition of long-
chain derivatives of polyunsaturated essential fatty acids, such as DHA or SDA to the diet 
normalized up to a higher degree the concentrations of neuropeptides and NTs in the ventral 
HC and the HPT when added to a HFD.  
Our results are in accordance to the recent indications that a microbiota gut-brain axis exists 
by which gut microorganisms modulate neuroendocrine and neurological mechanisms (Rhee 
et al., 2009). This fact has opened the possibility of modulating brain function and behaviour 
with probiotics, prebiotics and diet (Bermúdez-Humarán et al., 2019; Liu et al., 2016). For 
instance, changes in gut microbiota can modulate the peripheral and central nervous systems, 
resulting in altered brain functioning (Bienenstock et al., 2015; Mayer et al., 2015). Likewise, 
changes in gut microbiota may influence eating behaviour, memory, mood, and cognition and 
may be clinically relevant to a range of disorders, including anxiety or depression (Bauer et 
al., 2019; Galland, 2014; Liu et al., 2016) and eating disorders (van de Wouw et al., 2017). 
Even severe neurological disorders like autism, schizophrenia and neurodegenerative diseases 
have been linked to the gut microbiota (Bermúdez-Humarán et al., 2019; Westfall et al., 
2017). Likewise, specific probiotic strains of Bifidobacteria have been described to exert 
stress-related changes in behaviour and physiology (Savignac et al., 2015, 2014), whereas 
probiotic supplementation may positively impact learning capacity and LTP in rats with 
Alzheimer disease, most likely via the release of NTs or via a protective effect on serum lipid 
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profiles (Rezaeiasl et al., 2019). The use of several probiotics including B. breve has been 
reported as having antidepressive effects in mice and human patients (Yong et al., 2020). The 
evidences come also from studies directly linking the effects of probiotics to brain NTs or 
neuropeptides, mostly to dopaminergic neurotransmission (González-Arancibia et al., 2019). 
As examples, it has been reported that Lactobacillus strains may modulate neurochemicals 
related to affective disorders (DA, 5-HT) (Liu et al., 2016), that prebiotics may modulate 
anxiety through an effect on 5-HT receptors (Savignac et al., 2016), Clostridium butyricum-
based probiotic may also modulate hypothalamic DA and 5-HT (Cao et al., 2019). In vitro, 
Lactobacillus buchneri has a neuroprotective effects on SH-SY5Y-cultured neuroblastoma 
cells (Cheon et al., 2020). The mechanisms by which gut microbiota can influence brain 
neurochemistry and behaviour are not known, but the participation of the vagus nerve, the 
production of neuroactive microbial metabolites such as short chain fatty acids (SCFAs) or 
even bacterial-derived NTs have been proposed (Bauer et al., 2019; Bienenstock et al., 2015; 
Dinan and Cryan, 2017; Villageliú and Lyte, 2018; Yılmaz and Gökmen, 2020). Another 
possibility is the modification by intestinal bacteria-derived metabolites of gut hormone 
secretion, including glucagon-like peptide1 (GLP1) and peptide YY, leptin and ghrelin which 
could impact on hypothalamic neuroendocrine pathways to modify appetite (Ejtahed and 
Hasani-Ranjbar, 2019) and the activation state of several brain areas as the PFC or the HPT 
(Zanchi et al., 2017). Another intriguing potential mechanism is the production by 
microorganisms of proteins that have amino acid sequences identical to appetite-regulating 
peptides including α-MSH and NPY (Fetissov, 2019; Holzer and Farzi, 2014). Omega-3 fatty 
acids have been also shown to contribute to the brain integrity protection (Haast and Kiliaan, 
2015).  
A close inspection of the heatmaps indicates that, in the HPT, correlations between productive 
data and neurotransmitters in T3 and T4 are very similar to T1 and different to T2. This 
pattern will reinforce the idea that addition of vegetal protein and B. breve CECT8242 to a 
HFD reverses the effects of fat. Addition of long chain polyunsaturated omega-3 fatty acids 
even introduces negative correlations between productive data and NTs. In the ventral HC, 
changes introduced by probiotics and omega-3 fatty acids in relationship to HFD are small 
and, in fact, patterns in T3 and T4 are more similar to T2 than to T1. 
 
In conclusion, HFD provoked changes in appetite-related neuropeptides and NTs mostly of 
the dopaminergic pathway when fed to pigs, in a similar way to that described in rodents. 
These findings confirm the ability of an obesity-inducing diet to provoke changes in the 
signalling pathways of the brain controlling appetite and other behaviours. Furthermore, they 
reinforce the validity of the porcine model for nutritional studies.  
On the other hand, the inclusion of vegetal protein and B. breve CECT8242, especially if 
combined with long chain polyunsaturated omega-3 fatty acids as SDA and HDA, is able to 
partially reverse the changes induced by HFD. Besides the effects of probiotic and 
unsaturated fatty acid supplementation against weight gain and obesity, their potential 
benefits on brain function and neurochemical pathways deserves further research.  
Our results support the existence of a bottom-up control of brain processes by the gut 
microbiota and the gut endocrine signalling pathways. The analysis of the microbiota 
alterations induced by HFD in the porcine model and whether they can be restored by dietary 
supplementation with B. breve and long chain polyunsaturated omega-3 fatty acids, and the 
elucidation of the physiological mechanisms through which these effects are achieved will be 
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